Krystal Biotech, Inc. (KRYS) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $10.39B, a trailing price-to-earnings ratio of 44.0 and a free-cash-flow yield of 1.8%. Over the most recent reported fiscal year, revenue grew 33.9% and free cash flow per share grew 57.4%.